SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-022935
Filing Date
2020-02-03
Accepted
2020-02-03 16:12:08
Documents
8
Period of Report
2020-01-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d876973d8k.htm 8-K 26730
2 EX-4.1 d876973dex41.htm EX-4.1 5974
3 EX-4.2 d876973dex42.htm EX-4.2 6069
4 EX-4.3 d876973dex43.htm EX-4.3 5881
5 EX-4.4 d876973dex44.htm EX-4.4 5961
6 EX-4.5 d876973dex45.htm EX-4.5 5884
7 EX-4.6 d876973dex46.htm EX-4.6 5964
8 EX-10.1 d876973dex101.htm EX-10.1 40781
  Complete submission text file 0001193125-20-022935.txt   104824
Mailing Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746
Business Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746 512-614-1848
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32157 | Film No.: 20568770
SIC: 2834 Pharmaceutical Preparations